DGAP-News
True Leaf Announces Private Placement - Seite 2
True Leaf Pet Europe
Marketing | $175,000 |
Inventory Expansion | $125,000 |
General Admin |
$50,000 |
There is no material fact or material change about the Company that has not been generally disclosed. There is no minimum subscription amount for the Offering, and the securities underlying the Units issued pursuant to the Offering will be subject to a four month and one day hold period in accordance with applicable securities laws.
The Company may pay a cash finder's fee to eligible persons equal to 7% of the gross proceeds raised from applicable subscribers in the Offering.
This press release does not constitute an offer to sell or a solicitation of an offer to buy securities in the United States. The securities referenced herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the 'U.S. Securities Act'), or any state securities laws and may not be offered or sold in the United States except in compliance with one or more exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws.
About True Leaf:
Lesen Sie auch
True Leaf Medicine International Ltd., through its wholly-owned subsidiary 'True Leaf Pet', has entered the $104.9 billion global pet care industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada, the United States and Europe. The Company has also filed an application under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) to become a Canadian licensed producer through its 'True Leaf Medicine' subsidiary. It has passed through the security screening process of Health Canada's review and is currently in the final review stage before the 'pre-licensing inspection' approval.